Research Papers

25 of 756 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Meta-analysis of the Prognostic Value of microRNA-22 in Leukemia Patients.
Xia J; Xu D; Qin Y; Wan F; Ren Y; Bu C; Li T.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases.
Hadj Henni A; Gensanne D; Bulot G; Roge M; Mallet R; Colard E; Daras M; Hanzen C; Thureau S.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting.
Kanjanapan Y; Guduguntla G; Varikara AK; Szajer J; Yip D; Cockburn J; Fadia M.
Technol Cancer Res Treat (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturb…
Yuan S; Zuo W; Liu T; Fu H.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prediction of Prognosis of Tongue Squamous Cell Carcinoma Based on Clinical MR Imaging Data Modeling.
Liu J; Song L; Zhou J; Yu M; Hu Y; Zhang J; Song P; Ye Y; Wang J; Feng G; Guo H; An P.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of Hepatic Lesions After non-Thermal Tumor Ablation by Irreversible Electroporation in a Pig Model.
Jeon SM; Davaa E; Jiang Y; Jenjob R; Truong NT; Shin KJ; Jeong S; Yang SG.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcin…
Qu S; Wu D; Hu Z.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review.
Jafari A; Karimabadi K; Rahimi A; Rostaminasab G; Khazaei M; Rezakhani L; Ahmadi Jouybari T.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal C…
Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature R…
Guerini AE; Nici S; Magrini SM; Riga S; Toraci C; Pegurri L; Facheris G; Cozzaglio C; Farina D; Liserre R; Gasparotti R; Ravanelli M; Rondi P; Spiazzi L; Buglione M.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Quantitative Ultrasound for Evaluation of Tumour Response to Ultrasound-Microbubbles and Hyperthermia.
Sharma D; Carter H; Sannachi L; Cui W; Giles A; Saifuddin M; Czarnota GJ.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma.
Qing S; Gu L; Du T; Yin X; Zhang KJ; Zhang HJ.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer.
Lin X; Cai Y; Zong C; Chen B; Shao D; Cui H; Li Z; Xu P.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
Tavakoli Pirzaman A; Ebrahimi P; Hasanpour AH; Shakeri M; Babajani B; Pourali Ganji Z; Babaei H; Rahmati A; Hosseinzadeh R; Doostmohamadian S; Kazemi S.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Potential Medical Use of Fullerenols After Two Decades of Oncology Research.
Injac R.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5…
Xiang Z; Li G; Mu L; Wang H; Zhou C; Yan H; Huang M.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Nondeformed Ultrasound Image Production Method for Ultrasound-Guided Radiotherapy.
Li Q; Zhang F; Xi Q; Jiao Z; Ni X.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related…
Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Establishment of a Selective Liver Lobe Tumor-Bearing Mouse Model of Colorectal Cancer.
Han Z; Qiu B; Li L; Yu J; Zhu Z.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging.
Fernandes DA.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Percutaneous Application of High Power Microwave Ablation With 150 W for the Treatment of Tumors in Lung, Liver, and Ki…
Lanza C; Carriero S; Ascenti V; Tintori J; Ricapito F; Lavorato R; Biondetti P; Angileri SA; Piacentino F; Fontana F; Venturini M; Ierardi AM; Carrafiello G.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatmen…
Arrichiello A; Ierardi AM; Caruso A; Grillo P; Di Meglio L; Biondetti P; Iavarone M; Sangiovanni A; Angileri SA; Floridi C; Wood B; Carrafiello G.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review.
Li Y; Liu T; Wang X; Jia Y; Cui H.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and Safety of Transarterial Chemoembolization with DC Beads LUMI in the Treatment of HCC: Experience from a Te…
Biondetti P; Lanza C; Carriero S; Arrigoni F; Bevilacqua M; Ruffino A; Triggiani S; Sorce A; Coppola A; Ierardi AM; Venturini M; Guzzardi G; Carrafiello G.
Technol Cancer Res Treat (Unknown)
Published: 2023
2/6 Transparent
Funding Declared